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1. INTRODUCTION 
1.1. Psoriasis 
1.1.1 Clinical and histological features ofpsoriasis 
Psoriasis is a hyperproliferative, inflammatory skin disease of multifactorial origin, 
affecting approximately 2-3% the population worldwide. The symptoms may appear in 
various forms but either mild or severe forms of psoriasis affect the quality of life 
tremendously. Psoriasis is a lifelong inflammatory disease with spontaneous remissions and 
exacerbations (1), and patients experience disability at least at a level equivalent to that of 
patients with angina or hypertension (2). 
Clinically, the cardinal features of psoriatic lesions are erythema, induration and 
scaling. Involved areas are usually well demarcated and distributed in a characteristically 
symmetrical manner (3, 4). The disease has certain distinct but overlapping clinical 
phenotypes including chronic plaque lesions (psoriasis vulgaris), acute and usually self-
limiting guttate type eruptions, seborrhoeic psoriasis, pustular lesions, and at least 10% of 
these patients develop arthritis (5). Many triggering factors initiate or exacerbate psoriasis, 
including bacterial pharyngitis (group A streptococci) (6), psychological stress, HIV-1 and 
various medications (1). 
Histopathologically, plaque-stage lesions reveal significantly thickened epidermis with 
confluent parakeratotic scale, loss of the granular cell layer, and elongated rete ridges (Fig. 
1A). The papillary dermal blood vessels appear tortuous and dilated. The inflammatory cell 
infiltrate consists mainly of CD4+ and CD8+ T cells in the dermis and CD8+ T cells in the 
epidermis, accompanied by increased numbers of dermal dendritic cells, macrophages and 
mast cells (1, 7). 
1.1.2. Genetic studies in psoriasis 
It is generally accepted that psoriasis has a strong genetic background. The disease is 
frequently inherited and passed from one generation to the next, but it does not follow a 
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stripping), psoriatic uninvolved skin shows significantly higher epidermal cell proliferation 
than normal skin (16). Moreover, in psoriatic uninvolved epidermis, the clonogenic basal 
stem-cell population has been shown to be more sensitive to T cell-derived lymphokines than 
basal cells derived from normal epidermis (17). T cell-derived cytokines such as interferon 
( IFN ) -y , interleukin ( I L ) - 3 , and granulocyte-macrophage colony stimulating factor ( G M - C S F ) 
have a more pronounced growth-stimulatory effect on keratinocytes from uninvolved 
psoriatic skin as compared to healthy keratinocytes (17) (Fig. IB). These findings indicate 
that a key aspect of the development of symptoms is the inherent sensitivity of uninvolved 
psoriatic keratinocytes to exogenous proliferative signals such as mechanical stress or 
cytokines. This inherent sensitivity is partially due to the increased expression of a5 integrin 
(18) and its aberrantly produced ligands, fibronectin and the EDA' oncofetal fibronectin (19, 
20). Recent global gene expression profiling studies have also confirmed that uninvolved skin 
of psoriatic patients (also known as prepsoriatic and symptomless skin) shows numerous 
molecular differences as compared to healthy skin (3, 21). 
A 
Figure 1. Histological appearance of chronic psoriatic plaques and the mechanisms leading to 
keratinocyte hyperproliferation in psoriatic lesions. A chronic psoriatic plaque (A) reveals 
markedly thickened skin, parakeratosis, loss of the granular cell layer and dermal infiltration 
of lymphocytes, dendritic cells and macrophages. Skin-infiltrating T cells in the dermis and 
epidermis play an important role in inducing keratinocyte hyperproliferation (B): lymphokines 
such as granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin (IL)-3 and 
GM-CSF 
^IFN-y • 
/ IL-3 
© T cells 
EPIDERMIS 
DERMIS 
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interferon (IFN)-y produced by T cells stimulate the proliferation of stem cells in the basal 
layer of the psoriatic epidermis. 
1.1.4. Detection of gene expression differences between healthy and psoriatic uninvolved 
epidermis: a possible way to reveal psoriasis susceptibility factors 
Since keratinocytes in the uninvolved skin of psoriatic patients have an inherent 
sensitivity to proliferative signals derived from T cells, and this elevated sensitivity plays a 
crucial role in the development of psoriatic lesions (17, 18), identification of differentially 
expressed genes in the uninvolved psoriatic epidermis in comparison to healthy epidermis 
may reveal novel psoriasis susceptibility factors. 
For identifying gene expression differences, there are two main methods: in "closed 
systems," the expression of already known and annotated genes can be compared (such as the 
DNA microarray technique (22)), while in "open systems," in addition to comparing the 
expression of already known genes in different biological materials, yet uncharacterized genes 
can also be identified (23). Both systems have been used for studying genes that exhibit 
altered expression in psoriatic lesions (24) or in uninvolved psoriatic epidermis (3). 
Psoriasis-related gene expression profiling has led to the identification of new 
isoforms of known protein products, such as a new, skin-specific protease inhibitor 13, hurpin 
(25) and an alternately spliced mRNA isoform of a novel SI00 family member (26). These 
results show that, in addition to providing information about molecules that may play a role in 
psoriasis susceptibility and/or the precipitation of psoriatic symptoms, results of large-scale 
open system gene expression profiling experiments can be important for identifying 
transcripts with yet unknown functions. 
1.2 Non-coding RNA genes 
In the human genome, a large part of the transcriptional output is constituted of RNAs 
that lack protein-coding capacity (27, 28). In recent years, much data has accumulated 
showing that various, non-translatable, non-coding RNAs are synthesized in different cells. 
Surprisingly, many of these non-coding RNAs that were previously thought to be functionless 
have been found to be developmentally regulated or expressed in a cell- or tissue-specific 
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manner (27, 29, 30). These observations suggest that some of these transcripts are not solely a 
part of the large background of nonspecific transcription, but have a specific function and 
exert their action at the RNA level. In addition to housekeeping RNAs such as rRNAs, 
tRNAs, snRNAs and snoRNAs, a number of other non-coding RNAs have been discovered in 
recent years, including microRNAs and mRNA-like, larger transcripts (29). The regulatory 
non-coding RNAs identified to date fulfil a wide range of functions in the cells such as 
regulation of chromatin modification, transcription, alternative splicing, mRNA stability, 
translation or cell signaling (27, 31). 
A large fraction of the transcriptional activity in the human genome is derived from 
repeat sequences that are transcribed, such as long terminal repeats, short interspersed 
elements (SINEs), and long interspersed elements (LINEs) (29). Alu repetitive elements 
constitute 10% of the human DNA, they belong to the group of SINEs, and are generally 
considered to be functionless mobile elements playing role solely in the evolution of the 
human genome (32). However, recent studies have shown that some of the Alu elements show 
a regulated expression pattern and thus may have functions in stress response, chromatin 
organization or signaling events in the early embryo (32, 33). 
Relatively few non-coding RNAs have been identified or described in detail, since 
interest in the transcriptional activity of the genome has been focused almost exclusively on 
protein-coding genes. Most of the sequence related gene-finding algorithms, which have been 
developed to identify and define classical genes within the genomic sequence, are designed to 
identify open reading frames, polyadenylation signals, conserved promoter regions and splice 
sites typically associated with protein-coding genes (29, 34, 35). Although relevant 
computational and experimental approaches have now been initiated (29, 35), it is still 
difficult to estimate how many of these genes are present in the genome. Hence, open system, 
large-scale gene expression studies are still a valuable tool for identifying and characterizing 
novel genes that do not code for proteins but function as RNAs. 
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2. AIMS 
The aims of our study were: 
• To identify gene expression differences between the uninvolved epidermis of psoriatic 
patients and the epidermis of healthy individuals, in order to reveal novel psoriasis 
susceptibility factors 
• To confirm the differential expression of the identified transcripts in psoriatic 
uninvolved epidermis, using several independent samples 
• To investigate the regulation of the identified transcripts during keratinocyte 
proliferation and differentiation 
• To characterize functionally the differentially expressed transcripts and to investigate 
their possible role in the pathogenesis of psoriasis. 
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3. MATERIALS AND METHODS 
3.1 Human tissue samples 
Skin biopsies (6 mm punches) were taken from uninvolved and involved areas of 
psoriatic patients with the patients' informed consent and the approval of the local ethics 
committee. Control skin biopsies were obtained from healthy individuals undergoing plastic 
surgery. After removal of the subcutaneous tissue, the skin biopsies were incubated overnight 
at 4°C in Dispase solution (Grade II, Roche Molecular Biochemicals, Mannheim, Germany). 
On the following day, the epidermis was separated from the dermis. 
Tissue samples from various human organs were taken from patients who underwent 
different operations at the Department of Surgery, University of Szeged. Only non-involved, 
healthy tissues were used for RNA isolation. 
Tissue samples were stored in Trizol reagent at -70°C and RNA was isolated according 
to the instructions of the manual (Gibco BRL, Eggstein, Germany). 
3.2 Differential display 
Total RNA was isolated from epidermal samples using Trizol reagent according to the 
instructions of the manufacturer (Gibco BRL). The differential display experiment was 
carried out as previously described (36). 200 ng total RNA was reverse transcribed using three 
different one-base-anchored H-TuM primers (where M may be G, A, or C) of the RNAimage 
kit (GeneHunter Corporation, Nashville, TN, USA) according to instructions. Two 
micrograms of the reverse transcription reactions were PCR amplified with the arbitrary H-
AP1 primer of the GeneHunter kit in the presence of 0.04MBq cc[32P]dCTP. PCR 
amplification was carried out according to the GeneHunter manual. A portion of the resulting 
PCR products (3.5 pi) was mixed with loading dye and electrophoresed in 6% acrylamide 
DNA sequencing gels. Gels were dried and exposed to X-ray film for 1-3 days. Selected 
bands were excised from the dry sequencing gel, heated in 100 pi of water, cooled, and 
centrifuged briefly. The supernatant was transferred to a fresh centrifuge tube. For re-
amplification of differentially expressed fragments, 4 pi of the supernatant was used in PCR 
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amplification with the H-AP1 primer and with one of the H-TuM primers. Sizes of the 
amplified fragments were checked on agarose gels. Bands having the correct size were 
excised. After ethanol precipitation, the ends of isolated fragments were filled in using T4 
DNA polymerase (MBI Fermentas, Vilnius, Lithuania) and cloned into a Smal digested pSK 
vector, using the T4 DNA ligase (MBI Fermentas). 
3.3 Reverse Southern blot 
pSK vectors containing the cloned DD fragments were digested with Xbal and Xhol 
(MBI Fermentas), run on 1.5% agarose gels then the bands were transferred to NytranN nylon 
membrane (Schleicher & Schuell, Dassel, Germany). The same cDNAs (originating from 
healthy and psoriatic uninvolved epidermises) that were used for the DD experiments were 
again labeled with a[32P]dCTP, using the corresponding primers of the RNAimage kit and 
used as probes. Pre-hybridization and hybridization were carried out by standard methods (37) 
and the filters were exposed to X-ray films. 
3.4 Organotypic cultures of skin specimen 
The top layer of skin was prepared either from healthy control patients who underwent 
plastic surgery or from the uninvolved skin of psoriatic patients. The skin specimens were put 
on cellulose acetate/cellulose nitrate filters with 2.2 pm porosity (Millipore, Billerica, MA, 
USA) and placed on a stainless steel grid platform in a 25 mm2 Petri dish. The Petri dishes 
were filled with DMEM (Gibco BRL) supplemented with 10% FBS, 2 mM glutamine (Gibco 
BRL), 100 U/ml penicillin and 100 pg/ml streptomycin (Gibco BRL). As inducing factors, 
either 1 ng/ml IFN-y or the combination of 1 ng/ml IFN- y, 1 ng/ml GM-CSF and 0.3 ng/ml 
1L-3 were added to the medium. The above procedure enabled the tissues to be maintained at 
the air/liquid interface during the culture period. The explants were cultured at 37°C at 5% 
CO2 atmosphere for 3 days. Then tissue specimens were incubated in Dispase solution (Grade 
II, Roche Molecular Biochemicals) overnight at 4°C and on the following day the epidermis 
was separated from the dermis. The epidermis samples were placed in Trizol reagent and 
frozen at -70°C. 
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3.5 Cell cultures 
3.5.1 Culturing of HaCaT keratinocytes 
Human HaCaT cells, kindly provided by Dr. N. E. Fusenig (Heidelberg, Germany), 
were grown in 75cm2 cell culture flasks (Costar, Cambridge, MA, USA) and maintained in 
high glucose Dulbecco's modified Eagle's medium (high glucose DMEM, Gibco, Eggstein, 
Germany) supplemented with 10% fetal bovine serum (FBS) (Gibco), L-glutamine, 
penicillin/streptomycin and fungizone (Sigma, Budapest, Hungary) at 37°C in a humidified 
atmosphere containing 5% C02-
3.5.2 Synchronization of HaCaT keratinocytes 
HaCaT keratinocytes were synchronized by cultivating them at high density in the 
absence of serum. Cells were grown to 100% confluence in medium containing 10% FBS for 
5 days, then the medium was replaced by serum-free high glucose DMEM. The cells were 
grown in serum free media for 1 week. The synchronized cells were trypsinized and were 
subsequently seeded into 75cm2 culture flasks at a density of 5xl03 cells/cm2 in high glucose 
DMEM containing 10% FBS. Samples were taken from parallel cultures at different times 
after passing the cells to the high glucose DMEM containing 10% FBS. 
3.5.3 RNA polymerase inhibition 
For the specific inhibition of RNA polymerase II, subconfluent HaCaT cells were 
treated with 50 pg/ml a-amanitin (Boehringer-Mannheim, Mannheim, Germany) for 5 or 25 
hours. Subconfluent HaCaT cells were incubated for 12 hours with 1 pM or 3 pM 
concentrations of the specific RNA polymerase Ill-inhibitor, tagetitoxin (Epicentre 
Technologies, Madison, WI, USA). HaCaT cells were harvested and total RNA was isolated 
» 
using Trizol reagent (Gibco BRL). 
3.5.4 Stress treatments 
For in vitro expression experiments, subconfluent cultures of HaCaT cells were used, 
24h after passaging. For UV-B irradiation, cells were were washed with PBS and subjected to 
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UV-B irradiation (110 mJ/cm2) in PBS at room temperature. Immediately after irradiation, 
PBS was aspirated and culture medium was added to the culture dishes. Cells were harvested 
at 0, 3, 6, 12 and 24 hours after UV-B exposure. 
For treatment with microbial and fungal compounds, HaCaT cells were co-incubated 
with the following compounds for the indicated times: LPS (2.5 pg/ml, purified from 
Escherichia coli; 026:B6), Staphylococcus aureus peptidoglycane (PGN, no. 77140, 5 pg/ml, 
both Sigma, St. Louis, MO, USA), Mycobacterium tuberculosis cell wall extract made of the 
purified filtrate of M. tuberculosis cultured on Sauton medium (5 pg/ml, Human, Gödöllő, 
Hungary), or Candida albicans (0656; CBS, Delft, The Netherlands). Candida albicans was 
heat-inactivated at 56°C for 30 minutes prior to the experiments and 8 CandidalHaCaT cell 
was used for stimulation. 
For viral infection, HaCaT cells were infected with herpes simplex virus type 1 (HSV-
1, strain COS) at a multiplicity of infection of 0.01 pfu/cell, and cells were harvested after the 
indicated times. Mock-infected cells were similarly treated without addition of virus. 
For inhibition of translation, HaCaT cells were treated with cycloheximide (20 pg/ml, 
Sigma), and cells were harvested after the indicated times. 
3.6 Reverse transcription polymerase chain reaction (RT-PCR) 
Total RNA was isolated using Trizol reagent (Gibco BRL), according to instructions. 
Complementary DNA was generated from 1 pg of total RNA using the First Strand cDNA 
Synthesis Kit (MBI Fermentas) in a final volume of 20 pi. After reverse transcription, 
amplification was carried out using Taq DNA polymerase and the dNTP set from MBI 
Fermentas. PCR was carried out using the primers listed in Table I. Reactions contained a 
final concentration 0.66 pmol/pl of primer and 1.5 mM MgCU The amplification protocol 
included one cycle of initial denaturation at 94°C for 5 min, 35 cycles of denaturation at 94°C 
for 1 min, annealing at 55°C for 1 min, extension at 72°C for 2 min and one cycle of terminal 
extension at 72°C for 10 min. Ten microliters of PCR product was run on 1% agarose gel, 
stained with ethidium bromide, photographed and evaluated using a Kodak Edas 290 
densitometer and Kodak ID Digital Science software (Scientific Imaging Systems, New 
Haven, CT, USA). 
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Table L Sequences of primers and probes used for RT-PCR and for real time RT-PCR. 
Forward primer Reverse primer Detection/probe 
RABIO 
fibronectin 
PRINS exon 2 
fi-acu'n 
PRINS exon 1 
18S 
CATO AGTTTGG AAAAAGGACAACG 
AAGCCAATTTCCATTAATTACCGA 
AC 
GGCCCAGTGAGAACTACGGAA 
AGAGATGGCCATGGCTGCTT 
GCATCTTCCCTTGGCAAA 
CGGCTACCACATCCAAGGAA 
CCATATCC1TTCTATGTACAATGCCG agarose gel clccrtrophoresis 
TCTCATACTTGATGATGTAGCCGGTAA agarose gel electrophoresis 
TCATCTGAGCTTGAGTTAATCGGC 
ATTTGCGGTGGACGATGGAG 
GCCTAAAGGACATTTCGGTAT 
GCTGGAATTACCGCGGCT 
agarose gel electrophoresis 
agarose gel electrophoresis 
5'FAM 
TGC TGT r r r GGG TCC TAA CCA TC 
3' Black Hole2 
5 "Texas Red 
TGC TGG CAC CAG ACT TGC CCT C 
3 Black Hole2 
3.7 Quantitative real time RT-PCR 
For quantitative real time RT-PCR, 1 pg purified total RNA was reverse transcribed 
using the ¡Script kit (BioRad, Hercules, CA, USA). After reverse transcription, real time 
quantitative RT-PCR was performed to quantify the abundance of PRINS RNA. PRINS RNA 
expression data were normalized to the 18S ribosomal RNA expression data of each examined 
sample. The primers and TaqMan probes used for real time PCR are listed in Table I. The 
reactions were performed in duplicate, using the iQ Supermix (BioRad) in the iCycler 
(BioRad). 
3.8 RNA interference vector construction and transfection 
After analyzing the secondary structure using an RNA folding server 
(http://www.bioinfo.rpi.edu/applications/mfold/old/mfold), three different 19mer target 
sequences were selected for the sequence of PRINS. Target sequences were aligned to the 
human genome database in a BLAST search to ensure that the chosen sequences would work 
in a gene-specific manner in the subsequent siRNA experiments. Three selected siRNAs were 
synthesized and used in the experiments: AK696: TTTCTGGAATGATGTCCAA; AK862: 
TGTGGCCTGTGTTCTTTCA and AK1313: TTTTCTTTAAAGACTGCCA, where the 
numbers in the names of the oligos refer to the position in the transcript with GenBank 
accession number AK022045, which is included in the sequence of PRINS. As a control, a 
scrambled (nonsense) sequence of AK1313 siRNAs was used (SCO 13: 
AACTTTATCTCGGATCTAT). All of the oligos were synthesized with BamHI - Hindlll 
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linker sequences, according to the manual (Ambion, Inc, Austin, Texas, USA). The oligos 
were annealed and cloned into the BamHI - Hindlll sites of pSilencer 2.1-U6 hygro as 
described in the manual. All the plasmids constructed were confirmed by DNA sequencing. 
For stable transfection of HaCaT keratinocytes as well as HeLa cells, the siRNA constructs 
were purified by E.Z.N.A. Plasmid Miniprep kit I (peqlab Biotechnologie GmbH, Erlangen, 
Germany) and 2 pg of purified plasmids were transfected to the cells using the jetPEI reagent 
of QBioGene (Irvine, CA, USA), following the instructions of the manual. Stable transfected 
cells were selected in the presence of 200 pg/ml hygromycin, several independent clones were 
picked up from each transformants and were further analyzed by real time RT-PCR for 
evaluation of the gene specific silencing of PRJNS in the cells and by MTT assay to study the 
effect of PR1NS silencing on cell viability. 
3.9 MTT assay 
HaCaT keratinocytes and HeLa cells were seeded in wells of a 96-well plate at a 
density of 3x103 cells/well. Cells were either grown in serum-free media or in the presence of 
10% FBS for 168h. Medium was replaced with RPMI without phenol red and 50pg of MTT 
(3-(4,5-dimethyl thiazol-2-yl) 2,5-diphenyl tetrazolium bromide) (Sigma) was introduced into 
each well and incubated for 4h at 37°C. Living cells degrade MTT by the mitochondrial 
succinate dehydrogenase resulting in MTT formazan. The converted dye was solubilized with 
acidic isopropanol (0.04M HC1 in absolute isopropanol). The optical density of the wells was 
determined using a microplate reader (Multiscan v3.0, Labsystems) at 540nm. 
3.10 DNA microarray 
From HeLa cells transfected with gene-specific or control siRNA, RNA was isolated 
using Trizol reagent (Gibco BRL), and used for microarray experiments. For probe 
preparation, 2 pg of total RNA was reverse transcribed using poly-dT primed Genisphere 
Expression Array 900 Detection system (Genisphrere, Hatfield, PA, USA) as described (38, 
39). To compare gene expression profiles of cells transfected with PRINS-specific or control 
siRNA, a microarray comprising 18664 human ESTs, constructed in the Biological Research 
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Center, Szeged, Hungary was used. 
Scanned output files were analyzed using the GenePix Pro3.0 software (Axon 
Instruments Inc., Foster City, CA). 
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4. RESULTS 
4.1 Differential display as well as reverse Southern blot reveals differentially expressed 
genes in psoriatic uninvolved epidermis 
To identify gene expression differences in psoriatic uninvolved versus healthy 
epidermis, we performed a differential display analysis using two healthy and two uninvolved 
psoriatic epidermis samples. Twenty-five bands that showed consistent difference in the pair 
wise comparison of the samples were cut out from the acrylamide gel. The DNA content of 
the gels was removed by boiling, the isolated fragments were multiplied by PCR using the 
primers for the differential display experiments and after blunting, they were inserted to pSK 
vector. In the next round of evaluation, reverse Southern blot technique was applied to select 
clones for further analysis. Fragments have been cut out from the pSK vector, run in duplicate 
on agarose gels, blotted to nylon membranes, and hybridized with the radioactive labeled 
cDNAs from the healthy and from the uninvolved psoriatic epidermises. Figure 2A illustrates 
that differential expression was confirmed for three samples (No. 1, 2 and 3), while sample 
No. 4 showed about the same signal intensity with the two probes, and therefore it was 
excluded from further analysis. 
The three fragments showing elevated expression in uninvolved psoriatic epidermis 
(No. 1, 2 and 3) were sequenced and analyzed using the BLASTN program 
(http://www3.ncbi.nlm.nih.gov/BLAST/). Sample No. 1 was identical to the 3' end of the 
RAB10 gene (GenBank accession number AK023223), a member of the RAS oncogene 
family that belongs to the rab subfamily. Sample No. 2 was identical to the 3' end of the 
extracellular matrix protein fibronectin (GenBank accession number X02761) that has been 
demonstrated to have 24 differentially spliced variants in humans, one of which, the EDA+ 
isoform was shown to be overexpressed at the dermal-epidermal junction of psoriatic 
uninvolved skin (20). Sample No. 3 showed 100% homology to the 3' end of a cDNA 
(GenBank accession number AK022045) that had been sequenced from a 10-week old human 
embryo cDNA library, and it had no annotated protein product and function. 
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4.2 The identified transcripts show differential regulation during 
proliferation/differentiation of keratinocytes 
Since psoriasis is a skin disease characterized by abnormal proliferation and 
differentiation of epidermal keratinocytes, we aimed to investigate whether the expression of 
the identified transcripts was affected by the proliferation/differentiation state of the 
keratinocytes. For this purpose, we used synchronized HaCaT keratinocyte cultures which 
represent a model for keratinocyte proliferation and differentiation (40). In this model system, 
serum-starved, contact-inhibited cells (Oh) resemble suprabasal non-proliferating 
differentiated keratinocytes of normal epidermis, while the highly proliferative HaCaT cells 
after release from cell quiescence (24-168h) resemble the activated, differentiated, transiently 
amplifying keratinocytes. 
RT-PCR results revealed (Fig. 2B) that RAB10 mRNA was expressed approximately 
at the same level in different stages of keratinocyte proliferation/differentiation. In contrast to 
RAB10, fibronectin showed a highly regulated pattern of expression: the serum starved, 
contact inhibited HaCaT cells expressed a very low level of fibronectin mRNA, which 
increased dramatically with time after passaging and serum re-addition. The highest levels of 
total fibronectin mRNA coincided with the highest proliferation rate of HaCaT cells (48 and 
72 h). Since the primer pair we used to detect the fibronectin mRNA abundance was designed 
to border the EDA motif of fibronectin, we were able to detect both the EDA" and EDA+ 
isoforms of fibronectin (Fig. 2B) as well as changes in the ratio of these two isoforms (19). 
The novel cDNA, AK022045 showed the highest level of expression in the serum starved, 
contact inhibited HaCaT keratinocytes (Oh sample), and as the cells started to proliferate due 
to passaging and serum re-addition, the abundance of AK022045 cDNA dropped dramatically 
(24-96h samples) and did not seem to increase even after 168h, in the confluent culture (Fig. 
2B). 
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Figure 2. Verification of the differential expression of the identified transcripts in uninvolved 
psoriatic epidermis and their distinct regulation during keratinocyte proliferation and 
differentiation. A, Fragments identified by differential display were hybridized with 
radioactive labeled cDNAs from healthy and from uninvolved psoriatic epidermises (reverse 
Southern blotting). Differential expression was confirmed for samples No. 1, 2 and 3, while 
sample No. 4 showed about the same signal intensity with the two probes. B, The expression 
of RAB10, fibronectin and AK022045 transcripts (corresponding to sample no. 1, 2 and 3, 
respectively) was analyzed by RT-PCR in synchronized HaCaT keratinocytes after release 
from cell quiescence by using the primer pairs listed in Table I. 
4.3 Results of the in silico analysis of the cDNA AK022045 are indicative for a non-
coding RNA gene 
To further analyze the structural characteristics of the novel cDNA, we performed in 
silico localization, structural, translation and homology studies. Results of a genomic BLAST 
search (http://www3.ncbi.nlm.nih.gov/BLAST/) showed that the genomic sequence of the 
transcript AK022045 was localized on the short arm of human chromosome 10 (map position: 
10pl2.31). Comparison of the cDNA and genomic sequences revealed that the AK022045 
transcription unit is composed of two exons with an intron in between that is approximately 7 
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kb long. Surprisingly, in silico translation of AK022045 did not result in a translatable protein 
product in any of the three frames on either strand. The longest open reading frame on the 
sense strand was 180 nucleotides long encoding a 60-aa peptide; however, lacking the 
consensus Kozak's sequence, the ATG was not in a strong context of initiation. 
In order to map the 5' end of the full-length transcript, a set of RT-PCR experiments 
were carried out using cDNA from serum starved, contact inhibited HaCaT cells that 
expressed AK022045 mRNA at a high level. Primers (listed in Table II) were designed for the 
cDNA sequence of AK022045 and the genomic sequence upstream of AK022045, using the 
Primer3 software (http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi). Figure 3A 
shows that the most distant primer that resulted in a PCR product in our experiments was 
1483 bp upstream from the 5! end of the AK022045 cDNA. A putative TFIIB transcription 
factor binding site has also been identified on the genomic sequence proximal from the 
possible start of transcription. 
Further homology and similarity searches revealed that the full-length cDNA 
identified in HaCaT keratinocytes harbors 2 Alu elements and a short sequence element that 
shows approximately 70% similarity with an element in a small cytoplasmic RNA (G8 RNA) 
responsible for developing thermotolerance in Tetrahymena thermophila (Fig. 3B). These 
characteristics and the fact that the transcript could not be translated in silico into any protein 
sequence prompted us to hypothesize that AK022045 is a non-coding RNA gene. Since we 
detected a robust overexpression of this gene in psoriatic uninvolved epidermis and a stress-
induced expression in HaCaT keratinocytes, the full-length transcript was named Psoriasis 
«Susceptibility Related PNA gene induced by Stress (PRINS). 
Table II. Sequence of primers used for RT-PCR for the mapping of PRINS 5' end. 
Position* and sequen« of forward primers Position and sequence of reverse primers Expected length of ampltcon (bp) 
-534 TTTAGTAAACAATCTACCGAGCAGT +302 AAAACAAATGGTGGGCTC AG 
-370 CCAGCAAACCCAGCATAAGT 
-1118 CAGGCCAAACGATTATCTGC 
-1464 TTGTCTCGG AAAGGÀAAAGGA 
846 
771 
365 
905 
-1141 TGCTG C AG AT AATCGTTTGG 
-1483 CCTTTTCCTTTCCGAGACAA 
_ j 3 6 9 ACAGGGITTTGCCGTGTTAC 
"Relative to the first nucleotide in the sequence of the cDNA with accession number AK022045 
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Forward M -370 -1141 -1483 -2369 
Reverse +554 -370 -1118 -1464 
B 
Exon 1 Exon 2 
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Alu \ lu \ Alu + heat shockA 
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Figure 3. The structure of the full-length PRINS transcript in HaCaT keratinocytes. A, Total 
RNA was isolated from HaCaT keratinocytes, reverse transcribed and RT-PCR reactions were 
carried out using the primer pairs listed in Table II. Primers were designed for the already 
known sequence of the transcript with GenBank accession number AK022045 and for the 
genomic sequence proximal to its 5' end (M, DNA molecular weight marker). The most 
proximal primer pair did not result in an amplicon with the expected size, suggesting that the 
full-length transcript in HaCaT cells is at least 1483bp but no more than 2369bp longer than 
the originally sequenced cDNA, AK022045. B, Comparison of the cDNA and genomic 
sequences revealed that the AK022045 transcript consists of 2 exons. Homology searches 
revealed the presence of 2 Alu elements within the PRINS sequence and a sequence that 
showed approximately 70% similarity with an element necessary for the thermotolerance 
function of a small cytoplasmic RNA (G8 RNA) in Tetrahymena thermophila. 
4.4 PRINS is overexpressed in uninvolved psoriatic skin and its expression is regulated 
by T lymphokines 
Results of the differential display and the reverse Southern experiments have clearly 
indicated that PRINS is overexpressed in the uninvolved psoriatic epidermis relative to 
healthy epidermis. To confirm these results on several independent samples and to get 
insights into the possible role of PRINS in psoriasis, we performed real time RT-PCR analysis 
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on independent healthy (n=14), psoriatic uninvolved (n=13) and involved (n=14) epidermal 
samples. Results of the real time RT-PCR analysis confirmed that PR1NS was overexpressed 
in the psoriatic uninvolved epidermis (24-fold compared to normal epidermis, p<0.01; Fig. 
4A). The abundance of PRINS transcript in the psoriatic plaques did not reach the level 
observed in uninvolved psoriatic epidermis, however, it was still significantly, 12-fold higher 
compared to healthy epidermis (p<0,05; Fig. 4A). Fig. 4B shows a comparison of PRINS 
expression in the paired involved and uninvolved epidermis samples from eight psoriatic 
patients. In 6 out of 8 cases, higher levels of PRINS transcripts were detected in the 
uninvolved epidermis, as compared to psoriatic lesions (Fig. 4B). However, PRINS was 
upregulated in both involved and uninvolved epidermis in all studied patients, as compared to 
healthy controls. Interestingly, in two patients (P#4 and P#5), similar levels of PRINS 
expression could be observed in involved and uninvolved epidermis (Fig. 4B). 
To obtain further insights into the regulation of PRINS in the skin, we studied the 
expression of PRINS in organotypic cultures by real time RT-PCR. Healthy (n=5) and 
psoriatic uninvolved (n=5) epidermis specimen were treated with T-cell lymphokines, either 
with interferon-y (IFN-y) or the mixture of IFN-y, interieukin-3 (IL-3) and granolucyte 
macrophage colony-stimulating factor (GM-CSF), the latter combination known to induce 
keratinocyte hyperproliferation in uninvolved psoriatic, but not in normal keratinocytes in 
vitro (17). T-lymphokine treatment did not substantially affect the expression of PRINS in 
healthy epidermis (data not shown). In contrast, in uninvolved psoriatic epidermis, treatment 
with the T-lymphokine mixture resulted in a 5-fold decrease in PRINS expression compared 
to the untreated uninvolved epidermis (Fig. 4C). IFN-y treatment alone did not change PRINS 
expression in the uninvolved epidermis (Fig. 4C). The high expression of PRINS in the 
uninvolved, but lower expression in the lesional epidermis of psoriatic patients and the 
decrease of PRINS RNA level in uninvolved psoriatic epidermis, but not in normal epidermis 
m response to T-lymphokines suggests that PRINS overexpression plays a role in psoriasis 
susceptibility and not in the precipitation of psoriatic symptoms. 
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Figure 4. PRINS is overexpressed in the uninvolved epidermis of psoriatic patients and T-
lymphokines decrease its expression. A, PRINS expression was analyzed by quantitative real 
time RT-PCR in healthy (n=14), psoriatic uninvolved (n=13) and involved (n=14) epidermis 
samples. Primers listed in Table I were used. Values are shown as relative expression 
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compared to healthy epidermis (mean+SD, *p<0.05, **p<0.01, Student's /-test). B, PR1NS 
expression was compared by quantitative real time RT-PCR in matched pairs of uninvolved 
and involved epidermis samples of psoriatic patients (n=8). Values are shown as relative 
expression compared to average PRINS expression in healthy epidermis. C, Psoriatic 
uninvolved (n=5) skin specimen were treated with T-lymphokines in organotypic cultures for 
3 days. Total RNA was isolated from the epidermises and PRINS expression was compared 
by real time RT-PCR. Values are shown as relative expression compared to untreated healthy 
epidermis (mean+SE). 
4.5 PRINS is transcribed by RNA polymerase II 
PRINS was identified from a differential display experiment that was performed using 
arbitrary oligo dT primers, suggesting that the transcript may harbor a polyA tail indicative 
for transcription by RNA polymerase II. However, the presence of internal RNA polymerase 
HI promoters in the sequence would enable transcription by RNA polymerase III. In order to 
determine which RNA polymerase transcribes PRINS, we performed in vitro experiments on 
HaCaT keratinocytes using a specific RNA polymerase II inhibitor, a-amanitin and a specific 
RNA polymerase III inhibitor, tagetitoxin (41). 
Subconfluent HaCaT cells were treated with 50 pg/ml a-amanitin that has an effect 
only on RNA polymerase II but not on RNA polymerase III at this concentration (42). Results 
of real time RT-PCR analysis revealed that the expression of PRINS dropped dramatically 
after a 5-hour co-incubation with a-amanitin (10-fold compared to the untreated control) and 
incubation for 25 hours further reduced the expression of PRINS (33-fold compared to the 
untreated control) (Fig. 5A). The observed decrease in the RNA level of PRINS after a -
amanitin treatment was similar to that of RNA polymerase II transcribed genes such as IL-8 
(Fig. 5B). 
In contrast to a-amanitin, tagetitoxin (1 pM and 3 pM for 6 and 12 hours) did not 
change PRINS expression significantly compared to the untreated controls (Fig 5C). To 
confirm the effect of tagetitoxin at the applied concentrations, the expression of a well-
characterized RNA polymerase III transcribed gene, 7SL has also been studied. Real time RT-
PCR analysis showed that tagetitoxin decreased the expression of 7SL gene at both 
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concentrations, indicating that RNA polymerase III was effectively inhibited by these 
concentrations of tagetitoxin (Fig. 5D). 
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Figure 5. PRINS is transcribed by RNA polymerase II. HaCaT keratinocytes were co-
incubated either with the specific RNA polymerase II inhibitor, a-amanitin (20 pg/ml) for 5 
and for 25 hours (n=3) (A ,B) or with the specific RNA polymerase III inhibitor, tagetitoxin (1 
pM and 3 pM) for 12 hours (n=2) (C, D). Quantitative real time PCR analysis of PRINS {A, 
Q , the RNA polymerase II transcribed IL-8 (B) and 7SL, a well-characterized RNA 
polymerase III transcribed gene (D).Values are indicated as relative expression compared to 
the untreated controls. Error bars show SD of three independent experiments. 
4.6 PRINS is expressed in various human tissues and the level of expression shows large 
differences 
To investigate the tissue-specificity of PRINS, the absolute amount of PRINS RNA 
was determined by quantitative real time RT-PCR in healthy tissue samples from various 
human organs. PRINS was found to be expressed in all of the studied organ types (Fig. 6). 
Interestingly, the level of expression differed to a great extent in different organs. The lowest 
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level of PRINS RNA was detected in cardiac muscle, while the highest level was seen in 
veins. The level of expression was 18-fold higher in veins than in cardiac muscle. It is 
interesting to note that in comparison with all tissues studied, the abundance of the transcript 
was relatively low in the healthy epidermis. 
Figure 6. PRINS is expressed in various human organs. Total RNA was isolated from tissue 
samples from various human organs and PRINS RNA abundance was detected by quantitative 
real time RT-PCR. Data are expressed as fmol of PRINS in 1 ng of total RNA. Mean values 
of three to five independent samples are shown. 
4.7 PRINS is induced by environmental stress factors 
4.7.1 PRINS is induced by serum starvation and contact inhibition 
In our initial experiments, using the model system of synchronized HaCaT 
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keratinocytes, the AK022045 cDNA was abundantly expressed in contact-inhibited, non-
proliferating, differentiated cells while its expression decreased in proliferating cells (Fig. 
2B). To further confirm the changes in PR1NS expression in different 
proliferation/differentiation states of keratinocytes, we performed a quantitative real time PCR 
analysis of PRINS expression in this model system. Our results confirmed that PRINS is 
expressed at a high level in serum-starved, contact inhibited cells, while in proliferating cells, 
the abundance of PRINS RNA drops dramatically. After 12h, a 5-fold and after 24h, a 50-fold 
decrease could be observed compared to the serum-starved, contact inhibited cells (Fig. IN). 
During the 36-168h period of culture, the abundance of the PRINS transcript slightly 
increased, but it was still 8 to 16-fold lower than the expression observed in the serum-
starved, contact inhibited (Oh) ceils. These findings correlate well with the high expression of 
PRINS in uninvolved psoriatic epidermis but relatively lower expression in the psoriatic 
lesions with keratinocyte hyperproliferation. 
In addition, these observations also suggested that the high expression of PRINS was 
connected to the stressed state of HaCaT keratinocytes induced by contact inhibition and 
serum starvation. Therefore, we investigated whether serum starvation alone, as a stress 
signal, also induces PRINS. To this end, HaCaT keratinocytes were cultured in the presence 
of 10% FCS or in serum-free medium for 24 or 72h, and the expression of PRINS was 
analyzed by quantitative real time PCR. In serum-starved cells, the abundance of PRINS 
RNA increased up to 3-fold after 24h, and 6-fold after 72h, compared to the Oh controls (Fig. 
7B), while in the presence of serum, PRINS expression increased only in the 72h confluent 
culture. These results indicate that nutrient deprivation, representing a stress situation for 
keratinocytes, induces the expression of PRINS. 
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Figure 7. PRINS expression is dependent on the proliferation/differentiation of keratinocytes 
and it is induced by serum starvation. A, HaCaT keratinocytes were synchronized by serum 
starvation and contact inhibition, and after release from cell quiescence, samples were 
collected at the indicated time points. PRINS expression was determined by quantitative real 
time RT-PCR. Data are indicated as fold expression compared to the serum-starved, contact 
inhibited (Oh) samples. Values represent means of three independent experiments±SE. B, 
Subconfluent HaCaT keratinocytes were cultured either under normal serum conditions (10% 
ECS) or in serum-free medium (0% FCS) for 24 or 72 hours. PRINS expression was 
determined by quantitative real time RT-PCR. Data are indicated as fold expression compared 
to the initial, Oh samples. Values represent means of three independent experimentslSE. 
4.7.2 Microbial compounds and Candida albicans induce the expression of PRINS 
The inducibility of PRINS upon serum starvation and contact inhibition prompted us 
to hypothesize that PRINS is a stress-inducible RNA gene. Therefore, we aimed to investigate 
whether PRINS is induced by other types of stress cues relevant in skin. Epidermal 
keratinocytes, representing a barrier between the human body and the environment, are often 
exposed to various infectious agents such as bacteria and fungi. To determine whether 
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bacterial or fungal infection affects the expression of PRINS, HaCaT keratinocytes were 
treated with the bacterial cell wall components lipopolysaccharide (LPS), peptidoglycane 
(PGN), heat-inactivated Candida albicans, or Mycobacterium tuberculosis extract. HaCaT 
keratinocytes were continuously co-incubated with the microbial compounds or Candida 
albicans and samples were collected after 0, 3, 6, 12 and 24 hours. The level of the PRINS 
transcript was determined by quantitative real time PCR. All the microbial and fungal 
compounds tested caused an upregulation in PRINS expression (Fig. 8A, p<0.05). Treatment 
with Candida albicans caused a maximal (8-fold) induction after 24h, while LPS, PGN and 
Mycobacterium tuberculosis extract caused a maximal induction of PRINS after 12h (10 to 
14-fold increase). Co-incubation with these compounds for lh caused only a slight increase in 
PRINS expression 3, 6, 12 and 24h after treatment (data not shown). 
4.7.3 Ultraviolet B irradiation induces PRINS expression in HaCaT keratinocytes 
Ultraviolet (UV) radiation is one of the most important environmental stress factor, 
and its main target is the epidermis. UV-B (290-320 nm) is considered to be the causative 
agent of many of the harmful effects attributed to UV, causing DNA damage by crosslinking 
and modifying the pattern of gene expression (43). The effect of UV-B exposure (110 
mJ/cm2) on PRINS expression was examined 3, 6, 12 and 24 hours after the irradiation of 
HaCaT cells. Results of quantitative real time PCR analysis showed that UV-B irradiation 
significantly induced PRINS expression already after 3h (p<0.05; Fig. 8B), and peak 
expression was observed 24h after irradiation. 
4.7.4 Viral infection as well as inhibition of translation upregulates PRINS expression 
To investigate the effect of viral infection on PRINS expression, HaCaT cells were 
infected with herpes simplex virus type 1 (HSV-1) at a multiplicity of infection of 0.01 
pfu/cell. The abundance of PRINS transcript was determined by quantitative real time PCR 0, 
3, 6, 12 and 24 hours after infection. Compared to the time-matched mock-infected control, 
HSV-1 infection caused a 2.5-fold upregulation in PRINS expression already after 3h (Fig. 
8C, p<0.05). The abundance of PRINS RNA dropped back after 12h, but after 24h a second 
increase was observed. 
Viral infection causes complex changes in host cell biosynthesis, including inhibition 
of translation of selective host mRNAs (44). In order to investigate whether direct 
SZEGED 
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translational inhibition affects the expression of PRINS, HaCaT keratinocytes were treated 
with cycloheximide, an inhibitor of protein synthesis, at 20 pg/ml final concentration, and the 
abundance of PRINS RNA was determined by quantitative real time PCR. PRINS expression 
was rapidly induced by cycloheximide treatment, already after 30 minutes (p<0.01; Fig. 8D), 
and it was still elevated after 12 hours (Fig. 8D). 
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Figure 8. Environmental stress signals induce the expression of PRINS. A, HaCaT 
keratinocytes were co-incubated with heat-inactivated Candida albicans, lipopolysaccharide 
(LPS), peptidoglycane (PGN) or Mycobacterium tuberculosis extract for the indicated times. 
B, HaCaT keratinocytes were exposed to UV-B irradiation (110 mJ/cm2), and samples were 
collected at the indicated time points after irradiation. C, HaCaT keratinocytes were infected 
with herpes simplex virus type 1 (HSV-1) at a multiplicity of infection of 0.01 pfu/cell and 
samples were collected at the indicated times after virus adsorption. D, The translational 
inhibitor cycloheximide (20 pg/ml) was added to HaCaT cells and samples were collected 
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after the indicated times. PRINS expression was determined by quantitative real time RT-
PCR. Data are indicated as fold expression compared to the time-matched untreated controls. 
Values represent means of >4 independent experiments±SE (*p<0.05, **p<0.01, Student's t-
test). 
4.8 Gene-specific silencing of PRINS decreases the viability of cells exposed to stress 
Having established the inducibility of PRINS in response to a wide range of skin-
relevant stress factors, we addressed the question whether PRINS has any functional role in 
cellular stress responses. To this end, we used a vector-based RNA interference method to 
knock down the expression of PRINS in two different cell lines: HeLa cells, a human 
epithelial cell line originating from cervical carcinoma, and HaCaT keratinocytes. To evaluate 
the efficacy of the small interfering RNA (siRNA)-mediated PRINS depletion, PRINS RNA 
level was determined by quantitative real time PCR analysis in stably transfected HaCaT and 
HeLa cells. As negative control, we used a vector containing the scrambled sequence of one 
of the studied siRNAs of PRINS (SC). In addition to the basal level of PRINS RNA, we also 
determined the level of PRINS RNA after 72h of serum starvation in the transfected cells. 
One of the siRNAs tested (AK696) significantly downregulated PRINS expression both in 
HeLa and in HaCaT cells (Fig. 9A, B), indicating the effectiveness of this siRNA in 
degrading PRINS RNA. Moreover, the AK696 siRNA also repressed the induction of PRINS 
in serum-starved cells (Fig. 9A, B). After 72h of serum starvation, the abundance of PRINS 
RNA was still lower in the AK696 siRNA transfected cells than in the controls. 
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Figure 9. Gene-specific silencing by siRNA effectively downregulates PRINS. HaCaT 
keratinocytes (A) and HeLa cells (B) transfected with the pSilencer vector containing siRNA 
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specific for PRINS (AK696) or a scrambled sequence (control) were cultured in medium 
containing 10% or 0% FCS for 72h. PRINS expression was determined by quantitative real 
time PCR. Data are indicated as fold expression compared to the controls cultured in the 
presence of 10% FCS. Values represent means of at least two independent experiments+SD 
(*p<0.05, Student's /-test). 
To investigate the effect of PRINS knockdown, the morphology of stably transfected 
cells was examined by light microscopy. Interestingly, HeLa cells transfected with the siRNA 
AK696 showed a different morphology compared to both untransfected HeLa cells and to 
those transfected with the vector containing the scrambled sequence (HeLa I control) (Fig. 10). 
^£69<5-transfected HeLa cells (Fig. 10A) showed a more elongated, spindle-like morphology 
and formed less colonies as compared to the control HeLa cells (Fig. 10B). 
A B 
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Figure 10. PRINS depletion by RNA interference results in altered morphology in HeLa 
cells. HeLa cells were stably transformed with control vectors containing a scrambled 
sequence of one of the studied siRNAs (A) or vectors containing specific siRNA designed for 
the sequence of PRINS (B), and the morphology of the cells was studied by light microscopy. 
To investigate whether PRINS affects the viability of cells in stress conditions, the 
siRNA-transfected HaCaT and HeLa cells were cultured in the presence of 10% FCS or in 
serum-free medium for 168h, and cell viability was measured by MTT assay. In the presence 
of serum, cell viability was not significantly affected by the downregulation of PRINS, 
neither in HaCaT keratinocytes (Fig. 11 A) nor in HeLa cells (Fig. 1 IB). However, after 168h, 
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cell viability was significantly decreased in the serum-starved AK696 siRNA-transfected cells 
as compared to the controls containing the scrambled siRNA (p<0.001, both in HaCaT and 
HeLa cells) as well as compared to the AK696 siRNA containing cells cultured in the 
presence of serum (p<0.001 in HaCaT keratinocytes, p<0.05 in HeLa cells, Fig. 11 A, B). 
These findings demonstrate that the downregulation of PRINS impairs cell viability in serum-
starved cells, suggesting that PRINS is essential for cell survival under stress conditions. 
10% FCS 0% FCS 10% FCS 0% FCS 
Figure 11. Gene-specific silencing by siRNA decreases cell viability in serum-starved cells. 
HaCaT keratinocytes (A) and HeLa cells (B) transfected with the pSilencer vector containing 
siRNA specific for PRINS (AK696) or a scrambled sequence (control) were cultured in 
medium containing 10% or 0% FCS for 168h. Cell viability was measured by MTT assay. 
Data are indicated as relative values compared to the controls cultured in the presence of 10% 
FCS. Values represent means of at least six independent experiments+SD (*p<0.05, 
***p<0.001, Student's /-test). 
4.9 Gene-specific silencing of PRINS affects the gene expression profile of HeLa cells 
The observed effect of the gene-specific silencing of PRINS on cell morphology as 
well as on cell viability in stress conditions prompted us to hypothesize that PRINS exerts a 
specific function in the cells as a regulatory RNA, modifying the expression of protein-coding 
genes. In order to investigate whether PRINS regulates the expression of other transcripts, we 
compared the gene expression profiles in HeLa cells transfected with PRINS-specific siRNA 
(AK696) or with a scrambled sequence (control). For this, we used an oligonucleotide array 
comprising 18664 ESTs to initiate a comprehensive analysis of the transcriptional changes 
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that occur when PRINS is downregulated. 66 transcripts were differentially expressed in the 
PRINS siRNA transfected cells compared to controls: 40 genes with known function and 26 
transcripts with unknown function. Among the differentially expressed transcripts, 24 were 
downregulated and 42 were upregulated in the PRINS siRNA transfectants. Among the 
regulated transcripts, several encode proteins that are involved in cell cycle regulation, 
immunological processes and cell morphology. Current investigations focus on the analysis of 
the data and the validation of the gene expression differences by quantitative real time PCR. 
These experiments might reveal further cellular functions of PRINS beside the already 
demonstrated role in stress response. 
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5. DISCUSSION 
Psoriasis is a chronic inflammatory skin disease with multifactorial origin. Genetic, 
immunological and environmental factors play a role in the precipitation of the psoriatic 
symptoms, however, the interplay of these factors in the pathogenesis of psoriasis is still 
poorly understood (1,7). There is evidence that the healthy-appearing, uninvolved epidermis 
of psoriatic patients differs from the epidermis of the healthy individuals in its response to 
physical stress and T cell derived cytokines as well as in its molecular profile (16, 17, 21). 
Indentification of differentially expressed genes in the uninvolved psoriatic epidermis may 
reveal novel genetic susceptibility factors responsible for the elevated sensitivity of psoriatic 
uninvolved keratinocytes to proliferative signals. In this work, we performed a differential 
display analysis, a large-scale, "open system" gene expression study comparing gene 
expression profiles of uninvolved psoriatic and healthy epidermis. The advantage of such 
"open system" gene expression studies as compared with "closed systems" is that not only the 
expression of already annotated genes can be compared, but yet uncharacterized transcripts 
can also be identified. Characterization of differentially expressed, yet unknown transcipts 
may reveal novel pathways involved in psoriasis susceptibility and may provide new insights 
into the pathogenesis of this complex disease. 
Using differential display analysis comparing gene expression profiles of uninvolved 
psoriatic and healthy epidermis, we identified several differentially expressed transcripts that 
may play a role in psoriasis susceptibility. Some of the identified transcripts encode proteins 
with already characterized functions, such as the extracellular matrix protein, fibronectin (19). 
The high expression of fibronectin in psoriatic uninvolved epidermis is in good agreement 
with previous findings demonstrating the expression of fibronectin at the dermal-epidermal 
junction of psoriatic uninvolved but not of normal epidermis (18, 20). The fact that using 
differential display we could also detect abnormal fibronectin mRNA expression in psoriatic 
uninvolved epidermis confirmed that the experimental setup we applied was an appropriate 
tool for identifying gene expression differences in psoriatic uninvolved epidermis. Another 
transcript showing elevated expression in psoriatic uninvolved epidermis was RAB10, a 
member of the ras oncogene family. The RAB10 protein plays a role in vesicular transport 
(45). Elevated RAB10 gene expression has also been found previously in other pathological 
conditions such as hepatocellular carcinoma (45) and melanoma (46). 
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Beside genes with already known and characterized functions, we also identified a yet 
uncharacterized transcript showing elevated level in psoriatic uninvolved epidermis. 
Structural analysis of the novel transcript revealed a striking feature: the high density of stop 
codons in all three reading frames and a resulting lack of an extensive open reading frame. In 
silico translation of the sequence did not result in any protein product, suggesting that the 
novel transcript lacks protein-coding capacity and functions as a non-coding RNA. Homology 
studies on the full-length cDNA sequence also supported this hypothesis, since the sequence 
contains an element with high-level homology to a heat shock element in a small noncoding 
RNA, G8 (47). Moreover, it also harbors Alu repetitive elements, similarly to already 
characterized non-coding RNA genes such as the neuronspecifically expressed non-coding 
human RNA gene, BC200 (42). Based on its high expression in psoriatic uninvolved 
epidermis and the observed stress-inducibility in in vitro experiments, we named the novel 
transcript PRINS (Psoriasis-susceptibility Related RNA Gene /rcduced by -Stress). PRINS 
consists of two exons and it is located on chromosome 10. Using specific transcription 
inhibitors we showed that PRINS is transcribed by RNA polymerase II, despite the presence 
of internal RNA polymerase III promoters in its sequence. The full-length transcript expressed 
in HaCaT cells is longer than the cDNA detected in human embryonic tissue (GenBank 
accession number AK022045), and a putative TFIIB transcription factor binding site has been 
identified on the genomic sequence proximal from the possible transcription start site. Based 
on these characteristics of structure and transcription, PRINS belongs to the group of recently 
described mRNA-like non-coding RNA genes (including e.g. BORG, H19, PCGEM1), which 
are spliced, polyadenylated mRNA molecules containing a high density of stop codons and 
lacking an extensive ORF (48-50). 
To investigate the tissue-specificity of PRINS, we studied its expression pattern in 
various human tissues. PRINS RNA was detectable in all human tissue samples we studied 
and the level of its expression showed a great variability. These findings suggest that PRINS 
is a ubiquitously expressed transcript in the human body; however, its expression level is 
regulated in a tissue-specific manner. It is for future studies to identify elements responsible 
for the fine-tuning of tissue-specific expression of PRINS. Notably, the highest level of 
PRINS transcripts could be detected in veins. Psoriatic lesional skin is characterized by an 
expansion of the superficial dermal microvasculature (51, 52), and it has been shown that 
microvascular changes occur early in the development of psoriatic lesions (51). The high 
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expression of PRINS in veins indicates that endothelial cells may express PRINS which might 
regulate elements of angiogenesis-associated pathways. To support this hypothesis, further 
studies comparing the expression of PRINS in the dermis of healthy, uninvolved and involved 
skin need to be performed. 
The elevated expression of PRINS in psoriatic uninvolved epidermis was further 
confirmed by real time PCR analysis performed on several independent samples. 
Interestingly, the expression of PRINS in psoriatic lesions was higher compared to healthy 
epidermis, but lower than in the uninvolved epidermis. Moreover, lymphokine treatment, 
known to induce hyperproliferation of uninvolved psoriatic keratinocytes, decreased PRINS 
RNA level in psoriatic uninvolved but not in healthy epidermis. These results suggest that 
PRINS overexpression plays a role in psoriasis susceptibility and not in the precipitation of 
psoriatic symptoms. Moreover, these observations are in agreement with previous results 
showing that keratinocytes in the uninvolved skin of psoriatic patients differ from healthy 
keratinocytes in their responses to external stimuli (17, 19, 20). The overexpression of PRINS 
in the psoriatic uninvolved epidermis may reflect an altered regulatory extracellular milieu, 
but it is also possible that PRINS plays a regulatory role in the hyperproliferation of 
keratinocytes in psoriasis. Thus, PRINS may contribute to psoriasis susceptibility as a 
modifier gene. To date, no genetic loci associated with psoriasis susceptibility have been 
mapped on human chromosome lOp, where PRINS is coded. PRINS might contribute to 
Psoriasis susceptibility as a minor modifier gene beside the effect of the classical PSORS 1-9 
loci at chromosomes 19pl3, 17q25, lq21, lp, 6p21.3, 4q31-q34, 4q, 3q21 (1, 15). 
Interestingly, in two patients, PRINS transcript levels in the uninvolved epidermis were 
similar to those observed in psoriatic lesions, thus PRINS expression might be a newly 
identified factor reflecting the clinical heterogenity of psoriasis. This observation as well as 
the relatively large interindividual differences suggest that PRINS expression may be 
influenced by a yet unknown disease-associated factor in the epidermis of psoriatic patients. 
In synchronized HaCaT cells, a model system for keratinocyte proliferation and 
differentiation, PRINS expression was high in the serum-starved, contact-inhibited, non-
Proliferating cells, but much lower in proliferating cells, in good correlation with its high 
expression in vivo in psoriatic uninvolved epidermis, and lower expression in the psoriatic 
lesions characterized by the hyperproliferation of keratinocytes. 
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The upregulation of PRINS in serum-starved, contact-inhibited cells suggests that the 
high level of PRINS RNA is associated with the stressed state of cells. We showed that serum 
starvation alone is sufficient to induce PRINS expression, even without contact inhibition. 
These findings as well as sequence homologies to stress-induced transcripts such as the heat-
shock-inducible RNA, G8, and Alu elements(47, 53), prompted us to hypothesize that PRINS 
is induced also by other types of stress stimuli. Indeed, skin-relevant environmental stresses 
as divergent as UV-B irradiation, viral infection (HSV-1), various microbial compounds 
(LPS, peptidoglycane, Mycobacterium tuberculosis extract) and fungi (Candida albicans) 
increased the RNA level of PRINS in HaCaT keratinocytes. In most cases, peak expression 
was observed 12-24 hours after stimulation, indicating that PRINS may not be induced 
directly by the different stimuli, but its induction may rather be a late step in the integrated 
network of intracellular signaling induced by environmental stress signals. Bacterial, fungal 
and possibly also viral components can be recognized by Toll-like receptors in keratinocytes, 
and induce signal transduction pathways leading to the production of chemotactic and 
inflammatory mediators (54, 55). It is conceivable that the complex network of pathways 
induced by these environmental stress factors include a common stress response pathway, 
involving the upregulation of PRINS. In addition to skin-relevant stress signals, direct 
translational inhibition by cycloheximide also induced PRINS expression. It is remarkable 
that the stress-inducibility of PRINS resembles the regulation of short transcripts derived from 
repetitive elements including Alu, which are induced by various stress signals (56-58) and 
translation inhibition (32, 53, 56). The similarity in the regulation of short Alu transcripts and 
the ^/»-element harboring PRINS in response to stress stimuli suggests that induction of 
PRINS is a part of the general cellular stress response. 
In addition to Alu elements, several non-coding RNAs, including polyadenylated and 
spliced transcripts have been shown to be induced by different stress signals. G8, a small 
RNA gene showing homology to PRINS, is induced by heat shock in Tetrahymena 
thermophila (47), the gadd7 RNA is induced by DNA damaging agents (59), while adaptl5 
and adapm RNAs are induced in response to oxidative stress (60, 61). However, how these 
RNAs exert their function under stress conditions is not entirely understood. The so far 
identified non-coding RNAs can have diverse regulatory functions such as the regulation of 
chromatin modification, transcription, alternative splicing, mRNA stability, translation or cell 
signaling. BC200, a small RNA expressed in neurons plays a role in the posttranscriptional 
regulation of several proteins at the post-synaptic regions of dendrits (42, 62). The B2 gene, 
harboring the mouse orthologue of human Alu elements, represses mRNA expression in cells 
exposed to heat shock, thus functions as a transcriptional regulator (62, 63). 
To explore whether PRINS plays a functional role in the stress response of 
keratinocytes, we used RNA interference to knock down PRINS expression in HaCaT 
keratinocytes and in HeLa cells. Downregulation of PRINS by a specific siRNA significantly 
decreased the viability of cells after serum starvation, but not under normal serum conditions. 
This observation suggests that PRINS exerts its function in cells exposed to stress and might 
have a protective function against stress-induced cell death. Interestingly, knockdown of 
PRINS expression also resulted in morphological changes in HeLa cells. Since PRINS 
siRNA-transfected HeLa cells formed less and smaller colonies, it is conceivable that PRINS 
may also regulate genes involved in cell adhesion and cell-cell connections. 
To determine whether PRINS regulates the expression of other genes at the 
transcriptional level, gene expression profiles of PRINS siRNA-transfected and control HeLa 
cells were compared using DNA microarray. Several gene expression differences were found, 
indicating that PRINS may regulate the expression of protein-coding genes at the 
transcriptional level. Currently ongoing investigations focus on the validation of the gene 
expression differences by quantitative real time RT-PCR. Identification of genes regulated by 
PRINS may reveal novel factors related to psoriasis and may help to enhance our 
understanding about the pathomechanism of this disease. 
Several non-coding transcripts have been shown to be abnormally expressed in various 
human diseases, which emphasizes the importance of understanding their functions in normal 
cells. BC200, a small, normally neuronspecifically expressed RNA gene harboring a 
monomeric Alu element, is also expressed in several human tumor types (64). A recent study 
has shown that BC200 is expressed at high levels in invasive carcinomas of the breast, but it is 
not detectable in normal breast tissue or in benign tumors such as fibroadenomas, 
demonstrating the potential of BC200 expression to serve as a molecular tool in the diagnosis 
of breast cancer (65). MALAT-1 is overexpressed in non-small cell lung cancer (NSCLC), has 
a stable non-coding RNA product of 8 kb length, and the elevated level of MALAT-1 
expression was significantly associated with metastasis in NSCLC patients (66). Another non-
coding RNA gene (GenBank Acc. No.: AY 166681), recently identified from the NSCLC-N6 
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6. SUMMARY 
• Using differential display analysis comparing gene expression profiles of psoriatic 
uninvolved and healthy epidermis, we have identified several transcripts which may 
play a role in psoriasis susceptibility. 
• We further studied one of the yet uncharacterized transcripts showing elevated 
expression in uninvolved epidermis, which we named PRIMS (Psoriasis-susceptibility 
Related PNA Gene Induced by -Stress). Using in silico analysis, we showed that 
PRINS has no translatable protein product but harbours elements homologous to non-
coding RNA genes, suggesting that PRINS functions as a non-coding RNA. 
• We have demonstrated that the PRINS transcript expressed in HaCaT keratinocytes is 
transcribed by RNA polymerase II and that PRINS is widely expressed in various 
human tissues. 
• We have confirmed using real time RT-PCR analysis on several independent samples 
that PRINS is higher expressed in the uninvolved epidermis of psoriatic patients 
compared to both psoriatic lesional and healthy epidermis, suggesting a role for 
PRINS in psoriasis susceptibility. 
• We have demonstrated that PRINS is regulated by the proliferation and differentiation 
state of keratinocytes. 
• We have shown that environmental stress signals as divergent as serum starvation, 
UV-B irradiation, viral infection and various microbial compounds increase the RNA 
level of PRINS, indicating that PRINS is a stress-inducible gene. 
• Gene-specific silencing of PRINS by RNA interference revealed that downregulation 
of PRINS impairs cell viability after serum starvation but not under normal serum 
conditions, suggesting a protective role for PRINS under stress conditions. 
• We have shown that silencing of PRINS in HeLa cells results in altered cell 
morphology and causes changes in the gene expression profile, indicating that PRINS 
exerts its function by regulating the expression of other genes. 
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